Revolution Medicines, Inc. ($RVMD)
Filing Information
| Accession Number | 0001610717-26-000166 |
|---|---|
| Form Type | 4 |
| Filing Date | May 28, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
9,363
Total Value
$585,538.84
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Global Commercialization Officer | Common Stock | โ | May 26, 2026 | Exercise/Conversion | 3,121 | $33.62 | $104,928.02 | 57,521 | Direct | โ | View Details | |
Chief Global Commercialization Officer | Common Stock | โ | May 26, 2026 | Sale | 700 | $153.30 | $107,311.61 | 56,821 | Direct | โ | View Details | |
Chief Global Commercialization Officer | Common Stock | โ | May 26, 2026 | Sale | 2,000 | $154.06 | $308,121.80 | 54,821 | Direct | โ | View Details | |
Chief Global Commercialization Officer | Common Stock | โ | May 26, 2026 | Sale | 421 | $154.82 | $65,177.41 | 54,400 | Direct | โ | View Details | |
Chief Global Commercialization Officer | Stock Option (Right to Buy) | Derivative | May 26, 2026 | Exercise/Conversion | 3,121 | $0.00 | $0.00 | 106,109 | Direct | โ | View Details |